ZFIN ID: ZDB-FISH-150901-29590
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.
Fish name: pink1sh397/sh397
Genotype: pink1sh397/sh397
Targeting Reagent: none
HUMAN DISEASE MODELED by pink1sh397/sh397
Human Disease Conditions Citations
early-onset Parkinson's disease standard conditions Soman et al., 2017
GENE EXPRESSION
Gene expression in pink1sh397/sh397
RNA expression
Expressed Gene Structure Conditions Figures
apoeb standard conditions Fig. 9 from Flinn et al., 2013
mcu standard conditions Fig. 1 with image from Soman et al., 2017
micu1 standard conditions Fig. 3 with image from Soman et al., 2017
micu2 standard conditions Fig. 3 with image from Soman et al., 2017
smdt1a standard conditions Fig. 3 with image from Soman et al., 2017
th standard conditions Fig. 2 with image from Soman et al., 2017
Fig. 2 from Flinn et al., 2013
tigarb standard conditions Fig. 6 from Flinn et al., 2013
zgc:165532 standard conditions Fig. 3 with image from Soman et al., 2017
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in pink1sh397/sh397
Phenotype Conditions Figures
diencephalon has fewer parts of type diencephalon dopaminergic neuron, abnormal standard conditions Fig. 2 with image, Fig. 3 with image from Soman et al., 2017
diencephalon has number of diencephalon dopaminergic neuron, ameliorated chemical treatment by environment: ruthenium red Fig. 2 with image from Soman et al., 2017
dopaminergic neuron decreased amount, abnormal standard conditions Fig. 2, Fig. 3, Fig. 7 from Flinn et al., 2013
dopaminergic neuron differentiation process quality, abnormal standard conditions Fig. 2, Fig. 3, Fig. 7 from Flinn et al., 2013
microglial cell activation increased process quality, abnormal standard conditions Fig. 9 from Flinn et al., 2013
mitochondrial electron transport, NADH to ubiquinone decreased rate, abnormal standard conditions Fig. 4, Fig. 8 from Flinn et al., 2013
mitochondrial electron transport, ubiquinol to cytochrome c decreased rate, abnormal standard conditions Fig. 4, Fig. 8 from Flinn et al., 2013
muscle mitochondrion decreased functionality, abnormal standard conditions Fig. 4 from Flinn et al., 2013
muscle mitochondrion increased size, abnormal standard conditions Fig. 5 from Flinn et al., 2013
whole organism micu1 expression increased amount, abnormal standard conditions Fig. 3 with image from Soman et al., 2017
whole organism NADH dehydrogenase (ubiquinone) activity decreased occurrence, abnormal standard conditions Fig. 2 with image from Soman et al., 2017

CITATIONS  (4)